A fully Cancer Center-managed facility, the Genomics Technologies Shared Resource consists of theMicroarray and Molecular Cytogenetics facilities which provide access to specialized instrumentation andtechnical expertise in high-throughput genomic technologies and molecular cytogenetics for use inindividual and collaborative research programs. Services provided by the facility are: Microarray based genome-wide analysis of gene expression, genetic markers, and DNA copynumber aberrations Microarray based genome-wide analysis of chromatin modifications Validation of microarray and other data by high-throughput quantitative PCR Molecular cytogenetic analysis by fluorescence in situ hybridization (FISH) and spectral karyotyping(SKY) Evaluation and incorporation of emerging genomic technologies and promoting their integration intoresearch programs of HICCC investigators Investigator education and advice in adopting genome wide profiling and molecular cytogenetics intheir cancer research.The microarray component of the Genomics Technologies Shared Resource thus provides acomprehensive set of integrated genomic analysis tools and services that facilitate the high throughputanalysis of genetic and epigenetic alterations in human cancer in basic and translational researchprograms. These services, which are currently focused on procedures with several different microarrayplatforms from Affymetrix and Agilent, with ancillary methods including real-time PCR andPhosphorimaging, are closely linked to those provided by the Biomedical Informatics Shared Resource.The molecular cytogenetics facility provides SKY and FISH characterization of human and mouse tumorcells with efficient turnaround times utilizing state-of-the-art technologies. Together these facilities andservices provide an integrated platform for basic and translational genomics research in cancer biology atthe HICCC. Future plans include evaluating and potentially incorporating an ultra-high-throughputsequencing service into this Resource. During the last period of the CCSG, 53% of the investigators usingthe facility were Cancer Center members with peer-reviewed funding with those members representingfrom 50% to 98% of the usage of the available services. The proposed total operating budget of the facilityis $392,489, of which we are requesting $ 66,831 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-35
Application #
7669916
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-08-01
Project End
2013-06-30
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
35
Fiscal Year
2008
Total Cost
$58,750
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Petersen-Jones, Simon M; Occelli, Laurence M; Winkler, Paige A et al. (2018) Patients and animal models of CNG?1-deficient retinitis pigmentosa support gene augmentation approach. J Clin Invest 128:190-206
Sones, Jennifer L; Merriam, Audrey A; Seffens, Angelina et al. (2018) Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia. FASEB J 32:2574-2586
Park, Karen Sophia; Xu, Christine L; Cui, Xuan et al. (2018) Reprogramming the metabolome rescues retinal degeneration. Cell Mol Life Sci 75:1559-1566
Mumau, Melanie D; Vanderbeck, Ashley N; Lynch, Elizabeth D et al. (2018) Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol 200:1078-1087
Savage, Thomas M; Shonts, Brittany A; Obradovic, Aleksandar et al. (2018) Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3:
Caviglia, Jorge Matias; Yan, Jun; Jang, Myoung-Kuk et al. (2018) MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 67:2414-2429
Jauregui, Ruben; Park, Karen Sophia; Tsang, Stephen H (2018) Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet 39:544-549
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Yen, Bonnie; Fortson, Katherine T; Rothman, Nyanza J et al. (2018) Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. Immunohorizons 2:119-128

Showing the most recent 10 out of 331 publications